ABBLO PHARMA ApS: Financial statements 2025
CVR: 34080534
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
ABBLO PHARMA ApS (CVR 34080534) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 471,866 and a net result of DKK -152,259 compared with DKK 135,215 the year before. That is a decrease of 44.8% compared with the year before. Equity in the 2025 report amounted to DKK -238,088. The company had 1 employee in the financial year.
- Gross Profit
- DKK 471,866
- Profit/Loss
- DKK -152,259
- Equity
- DKK -238,088
- Total Assets
- DKK 1,161,191
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 472 t. | -152 t. | -238 t. | 1 |
| 2024 | - | 855 t. | 135 t. | -86 t. | 1 |
| 2023 | - | 806 t. | 107 t. | -221 t. | 1 |
| 2022 | - | 1.1 mio. | 301 t. | -328 t. | 1 |
| 2021 | - | 740 t. | 285 t. | -629 t. | 1 |
Official annual report
How creditworthy is ABBLO PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
ABBLO PHARMA ApS has published its annual report for 2024. Gross profit came to DKK 854,994, and the net result was DKK 135,215.
About ABBLO PHARMA ApS
ABBLO PHARMA ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2011. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nic Borch-Christensen and Mie Hjerrild Petersen. The board consists of Mie Hjerrild Petersen (chair) and Nic Borch-Christensen. The company is owned by ABBLO S.à.r.l. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 471,866 and a net result of DKK -152,259 compared with DKK 135,215 the year before. Equity in the 2025 report amounted to DKK -238,088.